Studies show that the translocation of hexokinase (HK), a key enzyme in glucose metabolism, can activate NLRP3 inflammasome, and inhibition of NLRP3 inflammasome can restore the expression and distribution of HK in AD model cells [5,6]. This evidence concerns the gene NLRP3 and Alzheimer disease.